3C Bio

Mobile SARS-CoV-2 (COVID-19) diagnostic laboratories – 2,400 rtPCR tests per lab/day
Analytics
Raised to Date: $76,075
Aggregate Commitments $
Wefunder
07/29/2020
11/20/2020
$50,000
$1,070,000
$100
Convertible Note
RegCF
Seed
$9,000,000
20%
Weekly Commitments $
11/30/2020
152%
7%
$667
102
Los Angeles, California
Healthcare & Pharmaceuticals
Medtech
B2B/B2C
Medium
High
3C Bio, with a valuation cap of $9 million, is raising crowdfunding on Wefunder. The company aims to build and deploy mobile diagnostic labs for the testing of SARS-CoV-2 infections. The testing will be focused on mission-critical communities, including schools, food and transportation workers, healthcare facilities, and critical infrastructure workers. Mark Mendel founded 3C Bio in April 2020 and has raised over $78,000 since its founding. The proceeds of the current crowdfunding campaign, with a minimum goal of $50,000 and a maximum goal of $1,070,000, will be used to purchase and build containerized labs, semi-trailer labs, lab equipment, reagents and supplies and for salaries, rents, and overheads. 3C Bio labs will be built in 53-inch semi-trailers or 40-inch containers, with massive scalability and deployability.
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-53,280 |
$0 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$9,415 |
$0 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$9,415 |
$0 |
Short-Term Debt |
$62,685 |
$0 |
Long-Term Debt |
$0 |
$0 |
Total Liabilities |
$62,685 |
$0 |
Analyst Report
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Other Deals

MedVector on StartEngine
The COVID-19 pandemic has grown the telehealth industry exponentially. A recent study of U.S medical specialists found that

Phoenix PharmaLabs on Netcapital
In the years before the world’s current COVID-19 crisis, America in particular faced a deadly and persistent threat…

C-Reveal Therapeutics on NetCapital
Cancer is the great, mysterious killer of medical science. As of January 2019, there were an